Merienne, Nicolas
Vachey, Gabriel
de Longprez, Lucie
Meunier, Cécile
Zimmer, Virginie
Perriard, Guillaume
Canales, Mathieu
Mathias, Amandine
Herrgott, Lucas
Beltraminelli, Tim
Maulet, Axelle
Dequesne, Thomas
Pythoud, Catherine
Rey, Maria
Pellerin, Luc
Brouillet, Emmanuel
Perrier, Anselme L.
du Pasquier, Renaud
Déglon, Nicole
Funding for this research was provided by:
Swiss National Science Foundation (31003A-165834)
Association Française contre les Myopathies
Agence Nationale pour la Recherche
Neuratris (ANR-11-INBS-0011)
Laboratoire d’Excellence Revive (Investissement d’Avenir (ANR-10-LABX-73)
French National Health Institute
INSERM
Novartis Foundation
EU Joint Programme–Neurodegenerative Disease Research
JPND (643417)
JPND
French National Research Agency
ANR
State Secretariat for Education, Research, and Innovation
SERI
Swiss National Science Foundation (FN 31ND30-166947/1)
Fondation pour la Recherche Médicale
This article is maintained by: Elsevier
Article Title: The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes
Journal Title: Cell Reports
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.celrep.2017.08.075
Content Type: article
Copyright: © 2017 The Author(s).